CN103554268A - 长效重组促卵泡激素及其应用 - Google Patents
长效重组促卵泡激素及其应用 Download PDFInfo
- Publication number
- CN103554268A CN103554268A CN201310529899.1A CN201310529899A CN103554268A CN 103554268 A CN103554268 A CN 103554268A CN 201310529899 A CN201310529899 A CN 201310529899A CN 103554268 A CN103554268 A CN 103554268A
- Authority
- CN
- China
- Prior art keywords
- hfsh
- fusion rotein
- restructuring
- cell
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310529899.1A CN103554268B (zh) | 2013-11-01 | 2013-11-01 | 长效重组促卵泡激素及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310529899.1A CN103554268B (zh) | 2013-11-01 | 2013-11-01 | 长效重组促卵泡激素及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103554268A true CN103554268A (zh) | 2014-02-05 |
CN103554268B CN103554268B (zh) | 2015-04-01 |
Family
ID=50008653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310529899.1A Active CN103554268B (zh) | 2013-11-01 | 2013-11-01 | 长效重组促卵泡激素及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103554268B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107636154A (zh) * | 2015-03-26 | 2018-01-26 | 阿塞勒隆制药公司 | 促滤泡素抑制素相关的融合蛋白及其用途 |
CN107759697A (zh) * | 2016-08-19 | 2018-03-06 | 安源生物科技(上海)有限公司 | 制备融合蛋白的方法 |
WO2019051954A1 (zh) * | 2017-09-15 | 2019-03-21 | 北京伟杰信生物科技有限公司 | 长效重组猪fsh融合蛋白及其制备方法与应用 |
CN109942717A (zh) * | 2019-04-24 | 2019-06-28 | 上海延立药业有限公司 | 一种长效重组人促卵泡激素及其制备方法和应用 |
CN110041434A (zh) * | 2019-04-28 | 2019-07-23 | 广州威生医药科技有限公司 | 长效重组fsh融合蛋白、其制备方法及其在母猪定时输精中的应用 |
CN111349154A (zh) * | 2018-12-21 | 2020-06-30 | 江苏众红生物工程创药研究院有限公司 | 一种重组人促卵泡激素及其制备方法和药物应用 |
CN113599503A (zh) * | 2021-07-28 | 2021-11-05 | 安徽中起生物科技有限公司 | 一种调节卵巢功能的生物制剂及其制备方法和应用 |
CN113717291A (zh) * | 2021-09-17 | 2021-11-30 | 南通大学 | 一种超长效稳定的fsh及其的表达重组方法及辅助生殖技术 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003064677A2 (en) * | 2002-01-31 | 2003-08-07 | The Trustees Of Columbia University In The City Of New York | Long-acting follicle stimulating hormone analogues and uses thereof |
WO2005058953A2 (en) * | 2003-12-12 | 2005-06-30 | Regeneron Pharmaceuticals, Inc. | Ogh fusion polypeptides and therapeutic uses thereof |
-
2013
- 2013-11-01 CN CN201310529899.1A patent/CN103554268B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003064677A2 (en) * | 2002-01-31 | 2003-08-07 | The Trustees Of Columbia University In The City Of New York | Long-acting follicle stimulating hormone analogues and uses thereof |
WO2005058953A2 (en) * | 2003-12-12 | 2005-06-30 | Regeneron Pharmaceuticals, Inc. | Ogh fusion polypeptides and therapeutic uses thereof |
Non-Patent Citations (1)
Title |
---|
S.C.LOW ET AL.: "Oral and pulmonary delivery of FSH–Fc fusion proteins via neonatal Fc receptor-mediated transcytosis.", 《HUMAN REPRODUCTION》, 31 July 2005 (2005-07-31) * |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107636154A (zh) * | 2015-03-26 | 2018-01-26 | 阿塞勒隆制药公司 | 促滤泡素抑制素相关的融合蛋白及其用途 |
US11001614B2 (en) | 2015-03-26 | 2021-05-11 | Acceleron Pharma Inc. | Method for treating a muscle-related disorder with follistatin-related fusion proteins |
CN107759697A (zh) * | 2016-08-19 | 2018-03-06 | 安源生物科技(上海)有限公司 | 制备融合蛋白的方法 |
WO2019051954A1 (zh) * | 2017-09-15 | 2019-03-21 | 北京伟杰信生物科技有限公司 | 长效重组猪fsh融合蛋白及其制备方法与应用 |
US11299527B2 (en) | 2017-09-15 | 2022-04-12 | Beijing Vjt Bio Co., Ltd. | Long-acting recombinant porcine FSH fusion protein and preparation method and application thereof |
CN111349154A (zh) * | 2018-12-21 | 2020-06-30 | 江苏众红生物工程创药研究院有限公司 | 一种重组人促卵泡激素及其制备方法和药物应用 |
CN109942717A (zh) * | 2019-04-24 | 2019-06-28 | 上海延立药业有限公司 | 一种长效重组人促卵泡激素及其制备方法和应用 |
CN110041434A (zh) * | 2019-04-28 | 2019-07-23 | 广州威生医药科技有限公司 | 长效重组fsh融合蛋白、其制备方法及其在母猪定时输精中的应用 |
CN113599503A (zh) * | 2021-07-28 | 2021-11-05 | 安徽中起生物科技有限公司 | 一种调节卵巢功能的生物制剂及其制备方法和应用 |
CN113717291A (zh) * | 2021-09-17 | 2021-11-30 | 南通大学 | 一种超长效稳定的fsh及其的表达重组方法及辅助生殖技术 |
Also Published As
Publication number | Publication date |
---|---|
CN103554268B (zh) | 2015-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103539862B (zh) | 一种长效重组促卵泡激素及其应用 | |
CN103554268B (zh) | 长效重组促卵泡激素及其应用 | |
CN103539860B (zh) | 一种长效重组人促卵泡激素融合蛋白 | |
CN103930134B (zh) | 长效促黄体激素(lh)化合物 | |
CN103554269B (zh) | 重组猪促卵泡激素融合蛋白 | |
CN103539861B (zh) | 长效重组人促卵泡激素融合蛋白 | |
RU2588650C2 (ru) | Фармацевтический препарат, содержащий рекомбинантный хорионический гонадотропный гормон человека | |
SA109300228B1 (ar) | تحضير صيدلاني من FSH مأشوب (rFSH) وعملية واستخدام التحضير الصيدلاني | |
US11299527B2 (en) | Long-acting recombinant porcine FSH fusion protein and preparation method and application thereof | |
US11883464B2 (en) | Nerve growth factor fusion protein, preparation method and use thereof | |
CN106256835A (zh) | 高糖基化人生长激素融合蛋白及其制备方法与用途 | |
CN103897064A (zh) | 长效重组人绒促性素融合蛋白 | |
CN107532172A (zh) | 产生促性腺激素的方法 | |
CN101189259A (zh) | 卵泡刺激素超激动剂 | |
CN107108731A (zh) | 增强促性腺素的生物活性的配体 | |
CN109922824A (zh) | 用于治疗血友病的截短的冯维勒布兰德因子多肽 | |
CN103804498B (zh) | 长效重组绒促性素及其应用 | |
EP2948164B1 (en) | Placenta growth factor in treating duchenne muscular dystrophy | |
CN106008717A (zh) | 一种长效重组glp-1融合蛋白及其制备方法和用途 | |
CN110041434A (zh) | 长效重组fsh融合蛋白、其制备方法及其在母猪定时输精中的应用 | |
AU2022333903A1 (en) | Fusion protein of interleukin 2 and application thereof in ibd | |
CN103833856A (zh) | 抑制taci-baff复合物形成的融合蛋白及其制法和用途 | |
Meng et al. | Fusion with CTP increases the stability of recombinant neuritin | |
CN116063570A (zh) | Il10单体融合蛋白及其应用 | |
CN112079922A (zh) | 抗人p40蛋白域抗体及其用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
DD01 | Delivery of document by public notice |
Addressee: GUANGZHOU NUOXIN BIOLOGICAL TECHNOLOGY CO., LTD. Document name: Notification of Passing Preliminary Examination of the Application for Invention |
|
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 510663 1 spire mountain road, Science Town, Guangzhou hi tech Industrial Development Zone, Guangdong Applicant after: GUANGZHOU YOULIANKANG MEDICINE TECHNOLOGY CO., LTD. Address before: 510663 1 spire mountain road, Science Town, Guangzhou hi tech Industrial Development Zone, Guangdong Applicant before: GUANGZHOU NUOXIN BIOLOGICAL TECHNOLOGY CO., LTD. |
|
CB03 | Change of inventor or designer information |
Inventor after: Hou Yongmin Inventor after: Lei Yao Inventor after: Li Yichen Inventor after: Liu Xiaoxia Inventor before: Hou Yongmin Inventor before: Lei Yao Inventor before: Li Yichen |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: HOU YONGMIN LEI YAO LI YICHEN TO: HOU YONGMIN LEI YAO LI YICHEN LIU XIAOXIA Free format text: CORRECT: APPLICANT; FROM: GUANGZHOU NUOXIN BIOTECHNOLOGY CO., LTD. TO: GUANGZHOU LIANKANG BIOLOGICAL TECHNOLOGY CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: GUANGZHOU WEISHENG PHARMACEUTICAL TECHNOLOGY CO., Free format text: FORMER OWNER: GUANGZHOU LIANKANG BIOLOGICAL TECHNOLOGY CO., LTD. Effective date: 20150702 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150702 Address after: 102 J1 building, 1 Tower Road, Luogang District, Guangdong, Guangzhou, 510663 Patentee after: Guangzhou vesun Medical Technology Co Ltd Address before: 510663 1 spire mountain road, Science Town, Guangzhou hi tech Industrial Development Zone, Guangdong Patentee before: GUANGZHOU YOULIANKANG MEDICINE TECHNOLOGY CO., LTD. |